Epigenetics of colorectal cancer: biomarker and therapeutic potential

G Jung, E Hernández-Illán, L Moreira… - Nature reviews …, 2020 - nature.com
Colorectal cancer (CRC), a leading cause of cancer-related death worldwide, evolves as a
result of the stepwise accumulation of a series of genetic and epigenetic alterations in the …

[HTML][HTML] DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer

D Müller, B Győrffy - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
DNA methylation is an epigenetic mechanism regulating gene expression. Changes in DNA
methylation were suggested to be useful biomarkers for diagnosis, and for the determination …

Epigenetic alterations in colorectal cancer: emerging biomarkers

Y Okugawa, WM Grady, A Goel - Gastroenterology, 2015 - Elsevier
Colorectal cancer (CRC) is a leading cause of cancer deaths worldwide. One of the
fundamental processes driving the initiation and progression of CRC is the accumulation of …

Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer

JMK Ng, J Yu - International journal of molecular sciences, 2015 - mdpi.com
Colorectal cancer (CRC) is a common malignancy and the fourth leading cause of cancer
deaths worldwide. It results from the accumulation of multiple genetic and epigenetic …

DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine

N Fatemi, S Tierling, HA Es, M Varkiani… - … journal of cancer, 2022 - Wiley Online Library
Colorectal cancer (CRC) is the second leading cause of cancer death worldwide that is
attributed to gradual long‐term accumulation of both genetic and epigenetic changes. To …

Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA

YD Han, TJ Oh, TH Chung, HW Jang, YN Kim, S An… - Clinical …, 2019 - Springer
Background Colorectal cancer (CRC) screening can effectively reduce disease-related
mortality by detecting CRC at earlier stages. We have previously demonstrated that the …

[HTML][HTML] Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer

TJ Oh, N Kim, Y Moon, MS Kim, BD Hoehn… - The Journal of Molecular …, 2013 - Elsevier
Aberrant DNA methylation has shown promise as a biomarker for the early detection of
cancer. To discover novel genes frequently methylated at an early stage in colorectal cancer …

[HTML][HTML] Epigenetic regulation of autophagy in gastrointestinal cancers

S Ghavami, M Zamani, M Ahmadi, M Erfani… - … et Biophysica Acta (BBA …, 2022 - Elsevier
The development of novel therapeutic approaches is necessary to manage gastrointestinal
cancers (GICs). Considering the effective molecular mechanisms involved in tumor growth …

Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle

FE Ahmed, NC Ahmed, PW Vos… - Cancer genomics & …, 2013 - cgp.iiarjournals.org
To present proof-of-principle application for employing micro (mi) RNAs as diagnostic
markers for colon cancer, we carried out global microarray expression studies on stool …

Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue

FE Ahmed, CD Jeffries, PW Vos, G Flake… - Cancer genomics & …, 2009 - cgp.iiarjournals.org
By routinely and systematically being able to perform quantitative stem-loop reverse
transcriptase followed by TaqMan® PCR expression analysis on stool and tissue samples …